Pediatric SJS/TEN Subdued by a Combination of Dexamethasone, Cyclosporine, and Etanercept. Issue 5 (September 2019)

• Record Type: Journal Article
• Authors: Coulombe, Jérôme; Belzile, Eugénie; Duhamel, Amélie; Rault, Pauline; Buteau, Chantal; DeBruycker, Jean-Jacques; Bussières, Jean-François
• Is Part Of: Journal of cutaneous medicine and surgery. Volume 23:Issue 5(2019)
• Page Start: 547
• Page End: 550
• Publication Date: 2019-09
• Subjects: dermatology -- drug reaction -- pediatric; Dermatology -- Periodicals; Skin -- Diseases -- Treatment -- Periodicals; Skin -- Surgery -- Periodicals; Dermatology -- Canada -- Periodicals; Skin -- Diseases -- Treatment -- Canada -- Periodicals; Skin -- Surgery -- Canada -- Periodicals; 616.5005
• DOI: 10.1177/1203475419861078
• Languages: English
• ISSNs: 1203-4754

Abstract

We report a case of an 17-year-old male with a drug reaction in the spectrum of Stevens-Johnson syndrome (SJS)/toxic epidermal necrolysis (TEN), triggered by carbamazepine, who was succesfully treated with the combination of dexamethasone, cyclosporine, and etanercept. This triple therapy halted and prevented skin epidermolysis without immediate or late onset complications.